Tag: Year

Positive week for Five-Star Business Finance Limited (NSE:FIVESTAR) institutional investors who lost 33% over the past year

Key Insights

  • Institutions’ substantial holdings in Five-Star Business Finance implies that they have significant influence over the company’s share price
  • 52% of the business is held by the top 9 shareholders
  • Insiders own 20% of Five-Star Business Finance

Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights

– Received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation (“BTD”) for CYB003, its proprietary deuterated psilocybin analog in development for the adjunctive treatment of Major Depressive Disorder (“MDD”) –

– Clinical site selection complete for Phase 3 multinational

Back To Top